Jeffrey M. Lipton
- Molecular Biology top 5%
- Hematology top 0.5%
- Immunology top 5%
- Genetics top 2%
- Physiology top 5%
- Co-authors
- Adrianna VlachosEva AtsidaftosSteven R. EllisDavid G. NathanPhilip J. LandriganJoel SchwartzClyde B. SchechterMarianne C. Fahs
- Topics
- RNA modifications and cancer (60 papers)Cancer-related gene regulation (52 papers)Epigenetics and DNA Methylation (31 papers)
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesFranceItaly
In The Last Decade
Jeffrey M. Lipton
136 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 146
- Molecular Biology 2.1k
- Hematology 1.2k
- Immunology 802
- Genetics 733
- Physiology 710
Countries citing papers authored by Jeffrey M. Lipton
This map shows the geographic impact of Jeffrey M. Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Lipton more than expected).
Fields of papers citing papers by Jeffrey M. Lipton
This network shows the impact of papers produced by Jeffrey M. Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Lipton. The network helps show where Jeffrey M. Lipton may publish in the future.
Co-authorship network of co-authors of Jeffrey M. Lipton
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Lipton. A scholar is included among the top collaborators of Jeffrey M. Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Lipton. Jeffrey M. Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 35 | |
| 3 | 23 | |
| 4 | 33 | |
| 5 | 77 | |
| 6 | 17 | |
| 7 | 5 | |
| 8 | 34 | |
| 9 | 167 | |
| 10 | 48 | |
| 11 | 17 | |
| 12 | 6 | |
| 13 | 383 | |
| 14 | 1 | |
| 15 | 5 | |
| 16 | 6 | |
| 17 | 46 | |
| 18 | 46 | |
| 19 | 13 | |
| 20 | 46 |
About Jeffrey M. Lipton
Jeffrey M. Lipton is a scholar working on Hematology, Genetics and Molecular Biology, having authored 142 papers that have together received 4.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (60 papers), Cancer-related gene regulation (52 papers) and Epigenetics and DNA Methylation (31 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (709 citations) and Immunology (802 citations). Jeffrey M. Lipton has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Adrianna Vlachos, Eva Atsidaftos, Steven R. Ellis, David G. Nathan, Philip J. Landrigan, Joel Schwartz, Clyde B. Schechter, Marianne C. Fahs, Jerome Ritz and Blanche P. Alter. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.